BioGenex Laboratories Unveils the NanoVIP System
BioGenex Laboratories announces the NanoVIP, an automated benchtop system for in situ hybridization that can run 10 different protocols simultaneously.
Read MorePosted by Chris Wolski | Oct 25, 2021 | Molecular Diagnostic Analyzers |
BioGenex Laboratories announces the NanoVIP, an automated benchtop system for in situ hybridization that can run 10 different protocols simultaneously.
Read MorePosted by Chris Wolski | Oct 21, 2021 | Cancer, Tissue Processing |
Researchers have found that a liquid biopsy method using lab-on-a-chip technology can identify biomarkers of concern before a tumor even forms.
Read MorePosted by Chris Wolski | Oct 21, 2021 | Prostate |
Researchers believe that men with Lynch syndrome could benefit from regular PSA testing from age 40 to detect early signs of prostate cancer.
Read MorePosted by Chris Wolski | Oct 20, 2021 | Breast |
Physicians are less likely to refer Black women with breast cancer for genetic counseling and testing services.
Read MorePosted by Chris Wolski | Oct 19, 2021 | Breast |
Quest Diagnostics will provide clinical laboratory testing using the Ki-67 IHC MIB-1 pharmDx (Dako Omnis) immunohistochemistry companion diagnostic.
Read More